Martin Oft

7.1k citations
55 papers · 5.2k · 2 hit papers · h-index 29

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Cytokine Signaling Pathways and Interactions
    • Cancer Cells and Metastasis
  • Immunology top 1%
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Cancer Immunotherapy and Biomarkers 26
    • Pancreatic and Hepatic Oncology Research 4
    • Cancer-related Molecular Pathways 3
    • T-cell and B-cell Immunology 12
    • Immunotherapy and Immune Responses 11
    • Immune cells in cancer 6

Martin Oft

53 papers receiving 5.1k citations

Martin Oft's Hit Papers

Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor 2010 · 484 citations
4840+6+13Years since publication250500750

Peers

Martin Oft
Comparison fields: 5 of 93
  • Oncology 1.9k
  • Immunology 1.5k
  • Virology 129
  • Molecular Biology 1.3k
  • Cancer Research 192
Replace Sunil Chada with:
Sunil Chada United States
Melita B. Irving Switzerland
Réjean Lapointe Canada
Luca Cassetta United Kingdom
Junichiro Mizuguchi Japan
Larry Kane United States
Tahseen H. Nasti United States
T. Kevin Howcroft United States
Richard V. Parry United Kingdom
Lydie Cassard France
Martin Oft relative to Sunil Chada United States Sunil Chada's profile →
Citations per field
00.5×2×4×6×
Sunil Chada · 1×
Citations per year

Countries citing papers authored by Martin Oft

Since Specialization
Citations

This map shows the geographic impact of Martin Oft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Oft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Oft more than expected).

Fields of papers citing papers by Martin Oft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Oft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Oft. The network helps show where Martin Oft may publish in the future.

Co-authors

The 25 scholars most cited alongside Martin Oft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin Oft Line = papers co-authored together Martin Oft links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
IL-23 promotes tumour incidence and growth
Hit paper breakdown →
2006865
2 1998547
3
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
Hit paper breakdown →
2010484
4 2011357
5 2002320
6 2012247
7 2014247
8 2018219
9 2016194
10 1996184
11 2012184
12 1996143
13 2007124
14 2010124
15 2019110
16 200894
17 202171
18 199868
19 200662
20 199860

About Martin Oft

Martin Oft is a scholar working on Oncology, Immunology, Virology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (26 papers), T-cell and B-cell Immunology (12 papers), Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (6 papers), Cervical Cancer and HPV Research (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), HIV Research and Treatment (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (1.5k citations), Virology (129 citations), Molecular Biology (1.3k citations) and Cancer Research (192 citations). Martin Oft has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Hartmut Beug, Karl‐Heinz Heider, Robert A. Kastelein, John L. Langowski, Terrill K. McClanahan, John Brian Mumm, Taiying Chen, Rosemary J. Akhurst, Allan Balmain and Jeanine D. Mattson. Their work appears in journals such as Annals of Oncology, Cancer Research, Science Translational Medicine, Cancer Cell and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact